V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011254 | 310008244 | null | 95.5 | Adjuvant (A) | 2017-07-19 | 2017-08-29 | DOXORUBICIN | N | N | 310020177 | IVE + METHOTREXATE |
| 310011255 | 310008253 | null | 83.3 | Palliative (P) | 2014-06-02 | 2014-04-13 | Sunitinib | N | N | 310020272 | TOPOTECAN |
| 310011256 | 310009904 | null | 77.8 | Disease modification (D) | 2014-01-27 | 2014-02-09 | VIDE | 2 | N | 310023229 | VEMURAFENIB |
| 310011257 | 310005167 | 1.74 | 92.7 | Palliative (P) | 2016-07-28 | 2018-04-24 | Methotrexate High Dose (3g/m2) | N | N | 310023294 | LENALIDOMIDE |
| 310011258 | 310008269 | 1.64 | 84.9 | Palliative (P) | 2016-03-24 | 2016-03-24 | BEAM + Alemtuzumab Allo SCT | N | N | 310023496 | PCV |
| 310011259 | 310005186 | 1.78 | null | Curative (C) | 2017-09-25 | 2017-12-27 | CHOEP | null | null | 310023536 | BEVACIZUMAB + IRINOTECAN + MDG |
| 310011260 | 310005188 | 1.91 | 85 | Curative (C) | 2016-12-31 | 2016-12-31 | VEDex | N | N | 310023544 | PEG INTERFERON |
| 310011261 | 310005191 | null | 43.2 | Palliative (P) | 2013-12-19 | 2014-04-05 | LANREOTIDE | 02 | N | 310023603 | CARBOPLATIN + DOCETAXEL |
| 310011262 | 310005193 | 1.82 | null | Curative (C) | 2017-06-05 | 2017-06-10 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 310023631 | METHOTREXATE |
| 310011263 | 310005213 | 1.67 | 91.7 | Palliative (P) | 2017-03-27 | 2017-04-04 | Dacarbazine | null | null | 310024026 | DABRAFENIB |
| 310011264 | 310005228 | 1.72 | 68 | Curative (C) | 2016-05-27 | 2018-03-30 | Atezolizumab | 02 | N | 310024239 | CHOP R + METHOTREXATE |
| 310011265 | 310011745 | 1.7 | 54 | Palliative (P) | 2013-08-20 | 2013-12-14 | CAPECITABINE + CARBOPLATIN | 2 | N | 310024290 | ALEMTUZUMAB |
| 310011266 | 310005235 | 1.74 | 85.6 | Curative (C) | 2016-11-02 | 2016-11-09 | IVE-R | 02 | N | 310024324 | ECX |
| 310011267 | 310011746 | 1.78 | 95.8 | Palliative (P) | null | 2014-06-09 | Gemcitabine + Oxaliplatin | N | N | 310024355 | CHOP R + METHOTREXATE |
| 310011268 | 310005239 | 1.61 | 62.3 | Adjuvant (A) | 2016-12-07 | 2017-06-14 | MITOMYCIN | 2 | N | 310024441 | GEMCITABINE + TREOSULPHAN |
| 310011269 | 310011312 | 1.68 | 69.7 | Neo-adjuvant (N) | null | 2018-03-24 | CVP R | N | N | 310024543 | CISPLATIN + PEMETREXED |
| 310011271 | 310005263 | 1.96 | 101.8 | Palliative (P) | null | 2018-11-16 | CAV | N | N | 310024633 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 310011272 | 310011933 | 1.93 | 73.7 | Curative (C) | 2017-06-07 | 2017-06-13 | DABRAFENIB + TRAMETINIB | 2 | N | 310024800 | BEAM + ALEMTUZUMAB |
| 310011273 | 310008319 | 1.61 | 151.6 | Palliative (P) | 2016-07-26 | 2016-11-01 | Olaparib | 02 | N | 310024826 | BEVACIZUMAB + CARBO |
| 310011274 | 310005276 | 1.87 | 85.3 | Curative (C) | null | 2018-10-22 | CYTARABINE + METHOTREXATE | N | N | 310024828 | METHOTREXATE HIGH DOSE |
| 310011275 | 310005287 | 1.75 | 59.1 | Palliative (P) | 2015-06-08 | 2015-06-08 | PCV | N | N | 310024907 | DABRAFENIB + TRAMETINIB |
| 310011276 | 310010814 | 1.7 | 74.1 | Palliative (P) | 2015-10-11 | 2015-12-02 | LANREOTIDE | 02 | N | 310024934 | INTERFERON |
| 310011277 | 310005294 | 1.68 | 93.7 | null | 2014-11-28 | 2015-04-14 | MITOMYCIN | 02 | N | 310024937 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 310011278 | 310011317 | 1.66 | 43.2 | Palliative (P) | 2018-11-21 | 2018-11-21 | IVE-R | N | N | 310024938 | IFOSFAMIDE + VINCRISTINE |
| 310011279 | 310005298 | 1.67 | null | Palliative (P) | 2016-08-16 | 2016-08-16 | INOVATYON Trial | N | N | 310024980 | METHOTREXATE HD + VINCRISTINE |
| 310011281 | 310009952 | null | null | Palliative (P) | 2019-02-07 | 2019-02-19 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 2 | N | 310025187 | HYDROXYCARBAMIDE |
| 310011282 | 310008344 | 1.66 | 68.8 | Palliative (P) | 2017-01-15 | 2017-01-19 | DOXORUBICIN | N | null | 310025231 | IRINOTECAN + MDG |
| 310011283 | 310005326 | null | 115.9 | Curative (C) | 2015-05-31 | 2015-10-05 | Cytarabine HD + Methotrexate HD | 2 | N | 310025252 | DABRAFENIB + TRAMETINIB |
| 310011284 | 310005328 | 1.7 | 66 | Palliative (P) | 2014-03-27 | 2014-04-08 | Vinblastine | 2 | N | 310025291 | VEMURAFENIB |
| 310011285 | 310005338 | 1.76 | null | Curative (C) | 2016-06-10 | 2016-06-18 | VAC | N | N | 310025341 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310011286 | 310005343 | 1.59 | null | Palliative (P) | 2013-09-19 | 2016-12-17 | Oxaliplatin + Modified de Gramont | N | N | 310025360 | PAZOPANIB |
| 310011287 | 310009960 | 1.66 | null | Palliative (P) | 2016-08-27 | 2016-08-27 | DOXORUBICIN | 2 | N | 310025414 | CAPECITABINE + OXALIPLATIN |
| 310011288 | 310005364 | 1.67 | 76.5 | Disease modification (D) | 2016-10-14 | 2016-11-30 | Capecitabine (21days) + Carboplatin | 02 | null | 310025608 | INTERFERON |
| 310011289 | 310005383 | null | null | Curative (C) | 2016-05-25 | 2016-05-25 | Dacarbazine | 02 | null | 310025710 | UKALL2014 |
| 310011290 | 310005390 | 0 | 85.6 | Palliative (P) | null | 2015-06-21 | Gemcitabine + Vinorelbine IV | null | N | 310025719 | PEG INTERFERON |
| 310011292 | 310005403 | 1.54 | 83.9 | Palliative (P) | 2016-03-10 | 2016-04-12 | Cisplatin + Etoposide po | 2 | N | 310000297 | CEV |
| 310011293 | 310005406 | 1.59 | null | Palliative (P) | 2019-01-28 | 2019-03-19 | ICON8 TRIAL | 02 | N | 310000433 | ICON TRIAL |
| 310011294 | 310005409 | 1.75 | 60.6 | Palliative (P) | 2018-06-21 | 2018-06-21 | Cisplatin + Fluorouracil + RT 5day | 1 | null | 310000469 | AZACITIDINE |
| 310011295 | 310008384 | 1.33 | 74.8 | Palliative (P) | 2017-07-27 | 2017-07-27 | Vemurafenib | 2 | N | 310000475 | CARBOPLATIN + DOCETAXEL |
| 310011296 | 310005415 | 1.63 | null | Palliative (P) | null | 2018-10-16 | Vinorelbine (oral) | N | null | 310000647 | ALEMTUZUMAB |
| 310011297 | 310005425 | null | null | Palliative (P) | 2017-11-27 | 2017-12-10 | Trabectedin | N | N | 310001118 | METHOTREXATE |
| 310011298 | 310005429 | 1.72 | 64.2 | Palliative (P) | 2017-09-12 | 2017-09-28 | Bendamustine + prednisolone | N | N | 310001330 | CARBOPLATIN + PEMETREXED |
| 310011299 | 310005438 | 1.54 | 62 | Palliative (P) | 2017-09-07 | 2017-11-01 | Atezolizumab | 2 | N | 310001682 | CARBOPLATIN + RT |
| 310011300 | 310005442 | 1.45 | null | Not known (9) | 2014-01-08 | 2014-03-08 | Capecitabine | N | null | 310001938 | CAPECITABINE |
| 310011301 | 310005446 | 1.71 | 67.6 | null | 2017-11-23 | 2017-11-23 | PEG INTERFERON | 2 | N | 310002273 | IMATINIB |
| 310011302 | 310005447 | 1.52 | 65.4 | Palliative (P) | 2015-07-09 | 2015-07-18 | FCR | N | N | 310002316 | ALEMTUZUMAB |
| 310011303 | 310005450 | 1.56 | null | Palliative (P) | 2016-01-01 | 2016-01-08 | ICON8 TRIAL | null | null | 310002562 | RUXOLITINIB |
| 310011304 | 310005454 | 1.73 | 62.3 | Curative (C) | 2015-08-22 | 2015-08-26 | Oxaliplatin + Modified de Gramont | N | N | 310002632 | DACARBAZINE + GEMCITABINE |
| 310011305 | 310009978 | 1.61 | null | Palliative (P) | 2018-02-26 | 2018-03-21 | ICON8 TRIAL | null | null | 310003095 | DOXORUBICIN |
| 310011306 | 310005462 | 1.62 | 68.9 | Curative (C) | 2019-07-08 | 2019-07-31 | LENALIDOMIDE | N | N | 310003401 | DHAP - R |